01.03.2013 Views

Understanding Clinical Trial Design - Research Advocacy Network

Understanding Clinical Trial Design - Research Advocacy Network

Understanding Clinical Trial Design - Research Advocacy Network

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

42<br />

UNDERSTANDING CLINICAL TRIAL DESIGN: A TUTORIAL FOR RESEARCH ADVOCATES<br />

Independent Variable Variable that is manipulated, sometimes experimentally,<br />

in order to observe its effects on a dependent variable.<br />

For example, in an investigation of the affect of drugs on<br />

cancer, the independent variable (e.g., drug type or dose)<br />

is manipulated and the affect of this manipulation can<br />

be seen in the change in the dependent variable or<br />

outcome (e.g., survival). A variable that is acted on or<br />

influenced by another variable.<br />

Inductive Methods A form of reasoning, also called empirical induction, in<br />

which a general law or principle is inferred from<br />

particular instances that have been observed.<br />

Inference A conclusion reached on the basis of evidence and<br />

reasoning.<br />

Informed Consent A process in which a person is given important facts<br />

about a medical procedure or treatment, a clinical trial,<br />

or genetic testing before deciding whether or not to<br />

participate. It also includes informing the patient when<br />

there is new information that may affect his or her<br />

decision to continue. Informed consent includes<br />

information about the possible risks, benefits, and limits<br />

of the procedure, treatment, trial, or genetic testing.<br />

Institutional Review An IRB is a committee with federal regulatory authority<br />

Board (IRB) to review and approve research involving human<br />

subjects. An IRB is composed of a diverse group of men<br />

and women with expertise in science, ethics, and other<br />

non-scientific areas.<br />

Intent-to-Treat In reality, not all patients who enroll in a clinical trial<br />

complete the trial as planned. They may drop out, die,<br />

switch treatments, etc. How to deal with the data of<br />

such patients is problematic because the patients who<br />

drop out are often different from those who complete<br />

the trial. Thus, biostatisticians often conduct two<br />

analyses—one including all patients assigned to<br />

treatment arms (i.e., those intended-to-be-treated) and a<br />

second including only patients who actually were treated.<br />

When the results of these two analyses differ, it is likely<br />

that the intervention influenced the propensity of<br />

patients to drop out of the trial.<br />

Interaction The situation in which a treatment difference (e.g.,<br />

difference between experimental and control) is<br />

dependent on another factor (e.g., study site, organ site,<br />

gender).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!